CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If your team is still defending budgets with vanity metrics, you lose ground.…

Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the content approval cycle drags on for weeks, sometimes months. Every delay costs…

For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to know not just if doctors were contacted, but whether those interactions drove…

Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance demands have grown tighter. Yet, proving the ROI of a pharma marketing budget remains…